In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking Oral Peptides: FAQs on Bioavailability, Safety, and Clinical Use AJMC BPC 157 Peptide Therapy for Healing INTRA V Buy BPC 157 99% Purity USA Research Peptides Element SARMs FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling